Mar 13, 2024 · Alirocumab is an injectable medicine that is given under your skin and may be used in adults with cardiovascular disease to reduce the risk of heart attack, stroke, and certain types of …

Mar 12, 2024 · Praluent (alirocumab) is an injectable medicine that is given under your skin which may be used in adults with cardiovascular disease to reduce the risk of heart attack, stroke, and certain …

Jul 15, 2024 · Detailed Alirocumab dosage information for adults. Includes dosages for Hyperlipidemia, Cardiovascular Risk Reduction, Heterozygous Familial Hypercholesterolemia and more; plus renal, …

Apr 10, 2025 · Alirocumab Pharmacokinetics Absorption Bioavailability Absolute bioavailability approximately 85% after sub-Q injection. Monthly dose-normalized exposure is similar between …

Dec 15, 2025 · Learn about the side effects of alirocumab, from common to rare, for consumers and healthcare professionals.

Aug 14, 2025 · Where do you inject Praluent (alirocumab)? Praluent is administered as a subcutaneous injection (an injection that goes under the skin) and can be self-administered by the patient or a …

Sep 19, 2024 · Praluent compared to Repatha What are the differences between Praluent and Repatha? The differences between Repatha (evolocumab) and Praluent (alirocumab) are their active …

Oct 30, 2025 · Detailed dosage guidelines and administration information for Praluent (alirocumab). Includes dose adjustments, warnings and precautions.

Nov 22, 2025 · Praluent package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.

Nov 14, 2025 · Frequently asked questions Praluent vs Repatha: What's the difference? What are PCSK9 Inhibitors and how do they work? How does Praluent work? How do you administer a …